QurAlis Corporation is a Cambridge (USA) based biotech company focused on developing precision therapeutics for ALS and other neurological diseases.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/19/18 | $5,500,000 | Seed |
Amgen Business Development MP Healthcare Venture Management Viva Biotech | undisclosed |
| 05/13/20 | $42,000,000 | Series A |
Amgen Business Development Dementia Discovery Fund  Dolby Family Ventures DROIA Oncology Ventures INKEF Capital LS Polaris Innovation Fund Mission BioCapital Mitsui Global Investment MP Healthcare Venture Management Sanford Biosciences | undisclosed |
| 03/10/23 | $88,000,000 | Series B |
ALS Investment Fund Amgen Ventures Dementia Discovery Fund Dolby Family Ventures DROIA Ventures EQT Life Sciences INKEF Capital LS Polaris Innovation Fund Mission Bay Capital Mission BioCapital Mitsui Global Investment MP Healthcare Venture Management Sanford Biosciences Sanofi Ventures | undisclosed |
